VRTX Vertex Pharmaceuticals Incorporated

VRTX Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 2 scans as of 2026-10-16 2 bull converging

POC $432.61 · VWAP $469.02 · +11.7% vs 12m avg buyer

basing vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

VRTX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist VRTX belongs to, members best 30-day change first — VRTX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech
@healthcare-scan
@healthcare
@ibb
@biotech-scan
@insider-universe
View watchlist →
ASAN+26.9% +4.5%1d +21.9%7d PINS+21.0% -2.7%1d +1.9%7d ZS+19.0% +7.3%1d +23.0%7d SHOP+18.5% -0.1%1d -0.5%7d ABNB+15.0% -2.1%1d -1.0%7d ISRG+13.6% +1.9%1d +6.0%7d NOW+12.9% +1.3%1d +12.0%7d ESTC+12.2% +4.3%1d +11.7%7d LLY+10.6% -2.5%1d +1.3%7d MRNA+9.9% -1.3%1d -8.2%7d RBLX+8.0% -2.0%1d +6.7%7d DDOG+7.2% +4.6%1d +9.1%7d MSFT+4.8% +0.7%1d -0.9%7d CRM+4.6% -0.7%1d +3.3%7d ZM+4.2% -0.5%1d +1.7%7d AAPL+3.2% -0.1%1d +1.2%7d AFRM+2.9% -3.2%1d -5.3%7d PLTR+2.6% +0.3%1d +5.8%7d UI+2.5% -1.4%1d -2.2%7d VRTX+1.5% -2.1%1d +4.8%7d TMO+1.3% -0.4%1d -2.3%7d FTNT+0.7% +4.0%1d +6.4%7d AMZN-0.5% -0.9%1d -0.8%7d CRWD-1.9% +8.3%1d +13.3%7d TSLA-2.1% -0.6%1d +4.9%7d HIMS-2.4% -4.9%1d -1.3%7d SNOW-2.8% +3.6%1d +6.1%7d PANW-3.2% +7.2%1d +11.3%7d UBER-3.9% -3.4%1d -5.2%7d CEG-4.0% -0.7%1d -6.6%7d ENPH-4.5% +0.8%1d +3.2%7d GOOGL-5.2% -1.2%1d -6.0%7d TSM-6.3% +1.5%1d +1.4%7d NVDA-6.5% -0.6%1d -1.5%7d U-7.5% +1.3%1d +1.0%7d NET-7.5% +7.3%1d +9.9%7d NFLX-7.7% -1.8%1d -6.6%7d NTLA-9.1% +0.5%1d -1.8%7d AVGO-9.4% -0.5%1d -2.1%7d ASML-9.9% +0.7%1d -4.3%7d TWLO-9.9% +3.2%1d +7.1%7d FSLR-10.4% +0.4%1d -0.4%7d BNTX-10.5% -1.7%1d +0.5%7d QCOM-10.8% +1.8%1d +2.2%7d CRSP-11.4% -1.2%1d +0.3%7d SOFI-11.7% -1.0%1d +0.5%7d IBKR-12.3% -2.4%1d -2.9%7d MRVL-12.4% +2.3%1d +0.3%7d MDB-13.4% +2.4%1d +9.9%7d META-13.6% -1.0%1d -9.4%7d AMD-15.9% +1.7%1d -2.3%7d COIN-17.0% -2.7%1d -5.0%7d FSLY-17.7% +8.7%1d +8.6%7d AKAM-21.0% +2.6%1d +6.5%7d INTC-29.1% +1.7%1d -3.2%7d BE-29.8% -11.2%1d -12.7%7d DOCN-34.0% +1.3%1d -5.5%7d ARM-36.8% +0.1%1d -7.7%7d EOSE-51.7% +1.2%1d -5.0%7d

Next earnings VRTX reports in 10 days Nov 2

Last report Aug 3

Reported the quarter ending 2026-06-30: revenue $3.33B, diluted EPS $4.31, net income $1.10B (SEC filing). Across the print the stock moved +0.3% (close before → first close after).

full note →

Against street estimates

How VRTX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.

8 most recent of 9 quarters · newest report Aug 3 · projection Oct 23

Result
Aug 3 4.754.73-0.3%In line
May 4 4.314.47+3.8%Beat
Feb 12 5.155.03-2.3%Miss
Nov 3 '25 4.584.80+4.9%Beat
Aug 4 '25 4.254.52+6.3%Beat
May 5 '25 4.294.06 GAAP ≠ -5.4%Miss
Feb 10 '25 4.023.98-1.0%In line
Nov 4 '24 4.134.38+6.0%Beat

News (last pull)

Headlines about VRTX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 15 days ago · Oct 8

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Sep 8 Desk Move VRTX — swing-kid sell
Sep 2 Desk Move VRTX — swing-kid buy
Aug 3 Catalyst VRTX earnings
May 4 Catalyst VRTX earnings